After demonstrating the EGFR/HER2‐mediated bispecificity of DTLP in pancreatic cancer cells, we used DTLP and AE (the chromophore of LDM) to produce DTLL and test whether DTLL exhibited potent antineoplastic bioactivity for pancreatic cancer therapy. Here, EGFR is linked to pancreatic neoplasm.